APA (7th ed.) Citation

C, R., A, A., P, B., I, B., AM, C., ATC, C., . . . P, B. (2026). Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck. Cancer treatment reviews, 148, 103175. https://doi.org/10.1016/j.ctrv.2026.103175

Chicago Style (17th ed.) Citation

C, Resteghini, et al. "Standardization of Objectives and Response Criteria for Neoadjuvant Immunotherapy in Resectable Squamous Cell Carcinoma of the Head and Neck." Cancer Treatment Reviews 148 (2026): 103175. https://doi.org/10.1016/j.ctrv.2026.103175.

MLA (9th ed.) Citation

C, Resteghini, et al. "Standardization of Objectives and Response Criteria for Neoadjuvant Immunotherapy in Resectable Squamous Cell Carcinoma of the Head and Neck." Cancer Treatment Reviews, vol. 148, 2026, p. 103175, https://doi.org/10.1016/j.ctrv.2026.103175.